Eli Lilly explores innovative approach to reducing unemployment in the UK with a study into weight-loss drugs
In an unexpected but intriguing development, American pharmaceutical titan Eli Lilly is set to start trials using weight-loss drugs as a strategic approach to combat unemployment in the UK. This pioneering study aims to explore whether the physiological and psychological benefits associated with weight loss can translate into better job prospects for individuals. The study, which represents a new intersection between health and economic policy, seeks to understand whether there is a direct correlation between weight management and an individual's ability to secure employment. Eli Lilly's move comes on the heels of securing a significant investment deal, suggesting solid backing…